Connect Biopharma is a San Diego company developing rademikibart, an antibody in trials for asthma and COPD. It last closed at $0.59 on Nov 20, down 6.08% on the day. The next earnings report for CNTB is expected around Tue, Mar 30, 2027, after the close. For the quarter ended Sep 2026, CNTB reported EPS of -$0.26 on revenue of $736,000, with revenue up 4500.0% from a year ago. Over its last 8 reports the stock moved an average of 9.0% the session after earnings. Over the last 12 months CNTB insiders bought $4.4M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CNTB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CNTB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CNTBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CNTB · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 23% below its 20 day and 53% below its 50 day average. It is 249% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 31), near oversold. The nearest support is the Pivot S1 at $0.57, and the nearest resistance the Pivot at $0.61.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 13.6%/day
Key levels
$3.8252 week high+547.5%
$2.06200 day average+249.2%
$1.58100 day average+167.8%
$0.9150 day average+54.2%
$0.87Swing high (Oct 30)+47.5%
$0.7320 day average+23.7%
$0.62Pivot R1+5.1%
$0.61Pivot+3.4%
$0.59Last close
$0.57Pivot S1−3.4%
$0.5552 week low−6.8%
$0.55Swing low (Nov 17)−6.8%
Indicators
RSI (14)
31.05
Weak, oversold below 30
Neutral
MACD
-0.10
Above its signal line
Bullish
Stochastic
26.7
Middle of its range
Neutral
ADX (14)
19.0
No clear trend
Williams %R
-84.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-114.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−19.0%
Change over 10 sessions
Bearish
ATR (14)
$0.08
Typical daily range, 13.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down, oversold
Short trendBearish
Long trendNeutral
MomentumWeak
StretchOversold
VolatilityHigh, 60.7%/day
Key levels
$3.8252 week high+547.5%
$2.06200 day average+249.2%
$1.58100 day average+167.8%
$0.9150 day average+54.2%
$0.87Swing high (Oct 30)+47.5%
$0.7320 day average+23.7%
$0.62Pivot R1+5.1%
$0.61Pivot+3.4%
$0.59Last close
$0.57Pivot S1−3.4%
$0.5552 week low−6.8%
$0.55Swing low (Nov 17)−6.8%
Indicators
RSI (14)
28.01
Oversold below 30
Oversold
MACD
-0.45
Below its signal line
Bearish
Stochastic
1.4
Near the bottom of its range
Oversold
ADX (14)
17.1
No clear trend
Williams %R
-98.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-98.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−71.1%
Change over 10 sessions
Bearish
ATR (14)
$0.36
Typical daily range, 60.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CNTB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CNTB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CNTB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CNTBHow many large options trades hit CNTB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CNTB in the last 90 days.
From SEC Form 4 filings by CNTB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CNTB is in one of them and how their past CNTB trades turned out.
Connect Biopharma is a biopharmaceutical company based in San Diego, California. It is developing rademikibart, an antibody designed to block a receptor involved in airway inflammation. The drug is in clinical trials for sudden worsening episodes of asthma and chronic obstructive pulmonary disease (COPD), which are lung conditions that make breathing difficult. The company's target market is patients with these diseases and the hospitals that treat them, although the drug is not yet approved for sale.